158 related articles for article (PubMed ID: 28256158)
1. Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.
Arcangeli S; Falcinelli L; Bracci S; Greco A; Monaco A; Dognini J; Chiostrini C; Bellavita R; Aristei C; Donato V
Br J Radiol; 2017 Mar; 90(1071):20160853. PubMed ID: 28256158
[TBL] [Abstract][Full Text] [Related]
2. Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.
Arcangeli S; Agolli L; Portalone L; Migliorino MR; Lopergolo MG; Monaco A; Dognini J; Pressello MC; Bracci S; Donato V
Br J Radiol; 2015 Apr; 88(1048):20140728. PubMed ID: 25645106
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.
Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1352-9. PubMed ID: 20056350
[TBL] [Abstract][Full Text] [Related]
4. Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases.
Jo IY; Kay CS; Kim JY; Son SH; Kang YN; Jung JY; Kim KJ
J Radiat Res; 2014 Jan; 55(1):105-12. PubMed ID: 23757513
[TBL] [Abstract][Full Text] [Related]
5. Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study.
Adkison JB; Khuntia D; Bentzen SM; Cannon GM; Tome WA; Jaradat H; Walker W; Traynor AM; Weigel T; Mehta MP
Technol Cancer Res Treat; 2008 Dec; 7(6):441-7. PubMed ID: 19044323
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.
Chang HJ; Ko HL; Lee CY; Wu RH; Yeh YW; Jiang JS; Kao SJ; Chi KH
Radiat Oncol; 2012 Dec; 7():222. PubMed ID: 23268786
[TBL] [Abstract][Full Text] [Related]
7. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
8. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.
Yoon SM; Suh R; Abtin F; Moghanaki D; Genshaft S; Kamrava M; Drakaki A; Liu S; Venkat P; Lee A; Chang AJ
Radiat Oncol; 2021 Jun; 16(1):99. PubMed ID: 34098977
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
[TBL] [Abstract][Full Text] [Related]
10. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.
Grills IS; Hope AJ; Guckenberger M; Kestin LL; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Wilbert J; Xiao Y; Belderbos J
J Thorac Oncol; 2012 Sep; 7(9):1382-93. PubMed ID: 22843086
[TBL] [Abstract][Full Text] [Related]
11. Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.
Shimizu D; Yamazaki H; Nishimura T; Aibe N; Okabe H
Anticancer Res; 2017 Oct; 37(10):5829-5835. PubMed ID: 28982908
[TBL] [Abstract][Full Text] [Related]
12. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
[TBL] [Abstract][Full Text] [Related]
13. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
[TBL] [Abstract][Full Text] [Related]
15. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.
Boda-Heggemann J; Frauenfeld A; Weiss C; Simeonova A; Neumaier C; Siebenlist K; Attenberger U; Heußel CP; Schneider F; Wenz F; Lohr F
Radiat Oncol; 2014 Jan; 9():10. PubMed ID: 24401323
[TBL] [Abstract][Full Text] [Related]
17. Analysis of intrafractional organ motion by megavoltage computed tomography in patients with lung cancer treated with image-guided stereotactic body radiotherapy using helical tomotherapy.
Aibe N; Yamazaki H; Nishimura T; Oota Y; Iwama K; Nakamura S; Ikeno H; Yoshida K; Okabe H; Yamada K
Anticancer Res; 2014 Dec; 34(12):7383-8. PubMed ID: 25503177
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of helical tomotherapy for inoperable non- small cell lung cancer: the Kyung Hee University Medical Center experience.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2014; 15(4):1545-9. PubMed ID: 24641365
[TBL] [Abstract][Full Text] [Related]
19. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Effects Between Central and Peripheral Stage I Lung Cancer Using Image-Guided Stereotactic Body Radiotherapy via Helical Tomotherapy.
He J; Huang Y; Shi S; Hu Y; Zeng Z
Technol Cancer Res Treat; 2015 Dec; 14(6):701-7. PubMed ID: 25911646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]